LYSINE BIOTECH PRIVATE LIMITED
Product development and Manufacture of drugs, biomarkers and vaccines from Protein and DNA
CIN:U74999TN2018PTC122879
| S.No | drugs delivery (IND) | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | Lysilirag-1-GLP-1 stimulates insulin secretion (IND/biobetter) | 2022 | ||
| 2 | Insulin LYSoctodec | 2022 | ||
| 3 | Lystictide-NPPA Congestive Heart Failure (IND) | 2022 | ||
| 4 | Lysspon-1- Alzheimer's (IND) | 2023 |
| S.No | antipeptide viral Drug and RNA-Targeted small antiviral peptide drug | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron specific antipeptide-RBD SPIKE antiviral for treatment of COVID-19. | 2022 | ||
| 2 | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 1st Fourteen-in-One GeneX viral-based RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID. | 2022 | ||
| 3 | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 2nd Fourteen-in-One GeneX viral-based RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID. | 2022 | ||
| 4 | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 3rd Fifteen-in-One GeneX viral-based RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID. | 2022 |
| S.No | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 1st Fourteen-in-One GeneX viral-based Recombinant Unique antigen peptide vaccine and RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | SARS-CoV-2 | 2022 | ||
| 2 | SARS-CoV-1 | 2022 | ||
| 3 | Human coronavirus OC43 | 2022 | ||
| 4 | Human coronavirus HKU1 | 2022 | ||
| 5 | Middle East respiratory syndrome-related coronavirus | 2022 | ||
| 6 | Infectious bronchitis coronavirus | 2022 | ||
| 7 | Turkey coronavirus | 2022 | ||
| 8 | Duck coronavirus | 2022 | ||
| 9 | Betacoronavirus HKU24 | 2022 | ||
| 10 | Bovine coronavirus isolate BCoV-ENT | 2022 | ||
| 11 | Betacoronavirus 1 | 2022 | ||
| 12 | Murine hepatitis virus strain MHV-A59 C12 mutant | 2022 | ||
| 13 | Canada goose coronavirus strain Cambridge_Bay_2017 | 2022 | ||
| 14 | Bulbul coronavirus HKU11 | 2022 |
| S.No | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 2nd Fourteen-in-One GeneX viral-based Recombinant Unique peptide vaccine and RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID. | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | Human coronavirus 229E | 2022 | ||
| 2 | Bat coronavirus | 2022 | ||
| 3 | Camel alphacoronavirus isolate camel/Riyadh/Ry141/2015 | 2022 | ||
| 4 | 229E-related bat coronavirus | 2022 | ||
| 5 | Unidentified human coronavirus | 2022 | ||
| 6 | Swine acute diarrhea syndrome related coronavirus | 2022 | ||
| 7 | Swine enteric alphacoronavirus | 2022 | ||
| 8 | Porcine enteric alphacoronavirus | 2022 | ||
| 9 | Rhinolophus bat coronavirus HKU2 | 2022 | ||
| 10 | Rhinolophus affinis bat coronavirus HKU2 | 2022 | ||
| 11 | Alpaca respiratory coronavirus | 2022 | ||
| 12 | BtRf-AlphaCoV/YN2012 | 2022 | ||
| 13 | Bottlenose dolphin coronavirus | 2022 | ||
| 14 | Wencheng Sm Shrew coronavirus | 2022 |
| S.No | Development of Alpha, Beta, Gamma, Delta, lamda & Omicron 3rd Fifteen-in-One GeneX viral-based Recombinant Unique peptide vaccine and RNA-Targeted small Unique antiviral peptide Drug to treat severe cases of PAN-COVID. | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | Human coronavirus NL63 | 2022 | ||
| 2 | Ferret coronovirus | 2022 | ||
| 3 | Mink coronavirus strain WD1127 | 2022 | ||
| 4 | Bat coronavirus | 2022 | ||
| 5 | Miniopterus schreibersii bat coronavirus 1 | 2022 | ||
| 6 | Feline infectious peritonitis | 2022 | ||
| 7 | BtMr-AlphaCoV/SAX2011 | 2022 | ||
| 8 | BtRf-AlphaCoV/HuB2013 | 2022 | ||
| 9 | BtNv-AlphaCoV/SC2013 | 2022 | ||
| 10 | Bat coronavirus CDPHE15/USA/2006 | 2022 | ||
| 11 | Myotis lucifugus coronavirus | 2022 | ||
| 12 | Scotophilus kuhlii bat coronavirus 512 | 2022 | ||
| 13 | Transmissible gastroenteritis. | 2022 | ||
| 14 | Porcine epidemic diarrhea virus | 2022 | ||
| 15 | Lucheng Rn rat coronavirus isolate Lucheng-19 | 2022 |
| S.No | Protein subunit vaccine | Product Development | Preclinical Testing | Commercial License (IP) |
| 1 | Protein subunit vaccine four in one Dengue 1-4 | 2022 | ||
| 2 | Protein subunit vaccine Chikungunya | 2022 | ||
| 3 | Protein subunit vaccine Sporozoite & Circumsporozoite (malaria) | 2022 | ||
| 4 | Protein subunit vaccine insulin (IlGF) (SGIV) | 2023 |